stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
ADAPTIMMUNE THERAPTCS ADRADAPY
$0.0367.60%0.0121

ADAPTIMMUNE THERAPTCS ADR (ADAPY)

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) Forecast

The ADAPTIMMUNE THERAPTCS ADR (ADAPY) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0309, representing a +2.94% increase from the current price of $0.03. The highest analyst price target is $0.0502, and the lowest is $0.0116.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month ADAPY Price Target
Average 0.0251 (-16.23% Upside)

Is ADAPTIMMUNE THERAPTCS ADR (ADAPY) A Buy Now?

Oscillators
NameValueAction
RSI(14)54.18Neutral
STOCH(9,6)36.34Neutral
STOCHRSI(14)100.00Sell
MACD(12,26)-0.00Sell
ADX(14)54.06Sell
William %R-10.96Sell
CCI(14)34.85Neutral
Buy: 0 · Sell: 4 · Neutral: 3Summary: Sell
Moving Averages
PeriodSimpleExponential
MA10
0.02
Buy
0.02
Buy
MA20
0.03
Buy
0.03
Buy
MA50
0.03
Buy
0.03
Buy
MA100
0.03
Buy
0.03
Buy
MA200
0.02
Buy
0.03
Buy
Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, ADAPY could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 4 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on ADAPY, as trading bullish markets is always a lot easier

  1. RSI (Relative Strength Index): The RSI(14) value of 54.18 indicates that ADAPY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 36.34 indicates that ADAPY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that ADAPY is overbought. This suggests that ADAPY price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 54.06 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of 34.85 indicates that ADAPY is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term ADAPY price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about ADAPTIMMUNE THERAPTCS ADR financial reports and earnings history, ADAPTIMMUNE THERAPTCS ADR (ADAPY) stock could reach $0.0597 by 2030, $0.2125 by 2040 and $0.373 by 2050. See the projected annual prices until 2050 of the ADAPTIMMUNE THERAPTCS ADR stock below:

  • ADAPTIMMUNE THERAPTCS ADR (ADAPY) is expected to reach an average price of $0.0826 in 2035, with a high prediction of $0.1262 and a low estimate of $0.0673. This indicates an +175.22% change from the last recorded price of $0.03.
  • ADAPTIMMUNE THERAPTCS ADR (ADAPY) stock is projected to chart a bullish course in 2040, with an average price target of $0.2047, representing an +582.30% change from its current level. The forecast ranges from a conservative $0.1294 to a sky-high $0.2125.
  • Our analysts predict ADAPTIMMUNE THERAPTCS ADR (ADAPY) to change +819.43% by 2045, soaring from $0.1782 to an average price of $0.2758, potentially reaching $0.2946. While $0.1782 is the low estimate, the potential upside is significant.
  • ADAPTIMMUNE THERAPTCS ADR (ADAPY) stock is expected to climb by 2050, reaching an average of $0.2814, a +837.89% change from its current level. However, a wide range of estimates exists, with high and low targets of $0.373 and $0.227, respectively, highlighting the market's uncertainty.

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) Year by Year Forecast

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) Price Forecast for 2026

The predicted value for ADAPTIMMUNE THERAPTCS ADR (ADAPY) in 2026 is set at an average of $0.0234. Estimates vary from a peak of $0.0502 to a trough of $0.0₁₇347, indicating an -22.12% surge from the present price of $0.03.

MonthAverageLowHighChange from today's price
December, 2026$0.0291$0.0116$0.0502-3.00%

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for ADAPTIMMUNE THERAPTCS ADR (ADAPY) is $0.0128, with a high forecast of $0.035 and a low forecast of $0.000063. This indicates an -57.33% decrease from the last price of $0.03.

MonthAverageLowHighChange from today's price
January, 2027$0.0162$0.00597$0.0333-46.06%
February, 2027$0.00967$0.0096$0.0259-67.78%
March, 2027$0.00267$0.017$0.0141-91.11%
April, 2027$0.00286$0.012$0.0076-90.45%
May, 2027$0.00647$0.0118$0.0044-78.44%
June, 2027$0.00394$0.0128$0.0111-86.88%
July, 2027$0.0246$0.00946$0.0283-18.01%
August, 2027$0.0248$0.00473$0.035-17.46%
September, 2027$0.0148$0.0054$0.0249-50.68%
October, 2027$0.0131$0.000063$0.0161-56.24%
November, 2027$0.024$0.0034$0.027-20.01%
December, 2027$0.0105$0.00713$0.0243-64.90%

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) Price Forecast for 2028

In 2028, ADAPTIMMUNE THERAPTCS ADR (ADAPY) is projected to reach an average price of $0.0103, with a high projection of $0.0304 and a low estimate of $0.000806. This indicates an -65.72% fall from the last price of $0.03.

MonthAverageLowHighChange from today's price
January, 2028$0.00457$0.00466$0.0178-84.78%
February, 2028$0.0097$0.00633$0.0304-67.67%
March, 2028$0.00268$0.00333$0.0141-91.05%
April, 2028$0.00867$0.00747$0.00746-71.10%
May, 2028$0.0203$0.035$0.0202-32.21%
June, 2028$0.0143$0.0292$0.0201-52.43%
July, 2028$0.0229$0.0286$0.014-23.54%
August, 2028$0.0199$0.0288$0.0273-33.76%
September, 2028$0.00919$0.000806$0.0167-69.35%
October, 2028$0.01$0.00473$0.02-66.58%
November, 2028$0.000593$0.00344$0.0103-98.02%
December, 2028$0.000541$0.00511$0.00213-98.20%

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) Price Forecast for 2029

The 2029 price forecast for ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) is $0.0212 on average, with a high prediction of $0.0435 and a low estimate of $0.00348. This represents an -29.49% decrease from the previous price of $0.03.

MonthAverageLowHighChange from today's price
January, 2029$0.011$0.00601$0.014-63.36%
February, 2029$0.00194$0.00348$0.0115-93.52%
March, 2029$0.0267$0.00731$0.0118-11.00%
April, 2029$0.0097$0.0123$0.0125-67.66%
May, 2029$0.0216$0.0226$0.0286-28.16%
June, 2029$0.027$0.0262$0.0228-9.99%
July, 2029$0.038$0.0528$0.0379+26.68%
August, 2029$0.0314$0.0463$0.0376+4.69%
September, 2029$0.0398$0.0455$0.031+32.69%
October, 2029$0.0358$0.0447$0.0435+19.36%
November, 2029$0.00621$0.0162$0.0325-79.30%
December, 2029$0.00471$0.01$0.00561-84.30%

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) Price Forecast for 2030

ADAPTIMMUNE THERAPTCS ADR Stock (ADAPY) is expected to reach an average price of $0.0348 in 2030, with a high forecast of $0.0597 and a low forecast of $0.0162. This signifies an +15.95% surge from the last price of $0.03.

MonthAverageLowHighChange from today's price
January, 2030$0.0136$0.0179$0.0126-54.63%
February, 2030$0.0142$0.0189$0.014-52.63%
March, 2030$0.00141$0.0206$0.0138-95.29%
April, 2030$0.0144$0.0162$0.00741-51.95%
May, 2030$0.0468$0.0195$0.0319+55.89%
June, 2030$0.0289$0.0457$0.0324-3.72%
July, 2030$0.0404$0.0317$0.0476+34.73%
August, 2030$0.0453$0.0449$0.0414+51.13%
September, 2030$0.0557$0.0705$0.0556+85.58%
October, 2030$0.0485$0.0634$0.0551+61.80%
November, 2030$0.0564$0.0624$0.048+88.03%
December, 2030$0.0517$0.0606$0.0597+72.48%

Similar to ADAPY